Phortas‘ Director, Senior Regulatory Lead Dr. Darius-Jean Namdjou, recently attended the annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA), held in Amsterdam in person. The event brought together key stakeholders in the European pediatric research landscape, spanning from academic excellence centers to ethicists, regulators and industry. Key highlights included: Industry case studies on up-to-date approaches to paediatric clinical trial des

At  Phortas , we are committed to advancing patient-centric and globally relevant drug development.  We’re pleased to announce that on 11 December 2025 at 13:00 CET,  Dr. Darius-Jean Namdjou , will present on a topic of increasing importance for our industry: the need for greater diversity, inclusion, and patient representation in clinical trials. 🙂  Underrepresentation across gender, ethnicity, socioeconomic status, and other factors continues to influence the quality and a